Breaking

Israeli strike on Iranian prison killed more than 70, says Iran state-affiliated media
UK police assess footage of Glastonbury acts over anti-Israel chants
Kneecap rapper charged with terrorism offense over alleged Hezbollah flag
Russia’s summer offensive in Ukraine underwhelms – but Kyiv won’t be celebrating
Netanyahu says ‘opportunities have opened up’ to free Gaza hostages following Iran operation
The last Hong Kong pro-democracy party that held street protests disbands
Turkish police detain dozens at banned Istanbul Pride march, lawmaker says
Severe heat waves hit southern Europe as local authorities warn against wildfire risks

World News
Science
Investing
Business
Search for:

Investing

Acceleration of RAD204 Phase 1 dose escalation trial

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

A$4.5M Placement to Underpin Resource Growth Strategy

DFS Presentation

A$2.7m Equity Placement to Fund Laverton Drilling Campaign

Fill Out & Get More Relevant News

Your name

Your email

Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.
Categories
- Business (1,158)
- Investing (2,836)
- Science (573)
- World News (3,452)

Disclaimer: digitaltradecenter.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest Posts
- Privacy Policy
- Terms & Conditions

Copyright © 2025 digitaltradecenter.com | All Rights Reserved

Top

World News
Science
Investing
Business

Type above and press Enter to search. Press Esc to cancel.